用法用量 |
Intravitreal
Age-related macular degeneration, neovascular:
Initial 6 mg once every 4 weeks (approximately every 28 days) for 4 doses. Subsequent doses are individualized based on visual assessments, and are administered as one of the following regimens:
(1)Every-8-week regimen: 6 mg on weeks 20, 28, 36, and 44
(2)Every-12-week regimen: 6 mg on weeks 24, 36, and 48
(3)Every-16-week regimen: 6 mg on weeks 28 and 44
Diabetic macular edema
6 mg once every 4 weeks (approximately every 28 days) for at least 4 doses, followed by 6 mg every 4 to 16 weeks (based on visual assessments)
Macular edema following retinal vein occlusion
6 mg once every 4 weeks (approximately every 28 days) for at least 3 doses, followed by 6 mg every 16 weeks (based on visual assessments) |